Molecular mechanisms that control interstitial fibrosis in the pressure-overloaded heart.
about
Transient receptor potential (TRP) channels and cardiac fibrosisMicroRNAs in Valvular Heart Diseases: Potential Role as Markers and Actors of Valvular and Cardiac RemodelingAntifibrotic therapies to control cardiac fibrosisMicroRNAs in heart failure: Small molecules with major impactDiastolic filling vortex forces and cardiac adaptations: probing the epigenetic nexusAssessment of Myocardial Fibrosis in Mice Using a T2*-Weighted 3D Radial Magnetic Resonance Imaging SequenceThe fibrosis-cell death axis in heart failureOsteopontin: At the cross-roads of myocyte survival and myocardial functionThrombospondin-4 regulates fibrosis and remodeling of the myocardium in response to pressure overloadCollagen XIV is important for growth and structural integrity of the myocardiumAnti-remodeling effects of rapamycin in experimental heart failure: dose response and interaction with angiotensin receptor blockadeMiR-133a regulates collagen 1A1: potential role of miR-133a in myocardial fibrosis in angiotensin II-dependent hypertensionPathophysiology of Aortic Valve Stenosis: Is It Both Fibrocalcific and Sex Specific?Phenotypic screen quantifying differential regulation of cardiac myocyte hypertrophy identifies CITED4 regulation of myocyte elongation.Increased afterload induces pathological cardiac hypertrophy: a new in vitro modelCellular mechanisms of tissue fibrosis. 6. Purinergic signaling and response in fibroblasts and tissue fibrosismiR-21 is associated with fibrosis and right ventricular failureIntegrins αvβ5 and αvβ3 promote latent TGF-β1 activation by human cardiac fibroblast contractionThe Genetic Challenges and Opportunities in Advanced Heart FailureThe calcium release-activated calcium channel Orai1 represents a crucial component in hypertrophic compensation and the development of dilated cardiomyopathy.Sphingosine 1-Phosphate Receptors: Do They Have a Therapeutic Potential in Cardiac Fibrosis?Effects of interleukin-33 on cardiac fibroblast gene expression and activity.Guanylyl cyclase (GC)-A and GC-B activities in ventricles and cardiomyocytes from failed and non-failed human hearts: GC-A is inactive in the failed cardiomyocyte.Global microRNA profiles and signaling pathways in the development of cardiac hypertrophyDiscrete microstructural cues for the attenuation of fibrosis following myocardial infarction.Roles of cGMP-dependent protein kinase I (cGKI) and PDE5 in the regulation of Ang II-induced cardiac hypertrophy and fibrosis.Repression of cardiac hypertrophy by KLF15: underlying mechanisms and therapeutic implications.Augmented cardiac hypertrophy in response to pressure overload in mice lacking ELTD1.Obesity and atrial fibrillation.Cdon deficiency causes cardiac remodeling through hyperactivation of WNT/β-catenin signalingEnhanced sensitivity to low dose irradiation of ApoE-/- mice mediated by early pro-inflammatory profile and delayed activation of the TGFβ1 cascade involved in fibrogenesis.Cardiac steatosis potentiates angiotensin II effects in the heart.The complex regulation of tanshinone IIA in rats with hypertension-induced left ventricular hypertrophyCardiomyocyte-specific miRNA-30c over-expression causes dilated cardiomyopathy.Effects of miRNA-455 on cardiac hypertrophy induced by pressure overload.Left ventricular systolic dysfunction in asymptomatic Marfan syndrome patients is related to the severity of gene mutation: insights from the novel three dimensional speckle tracking echocardiography.Signal regulatory protein-α protects against cardiac hypertrophy via the disruption of toll-like receptor 4 signalingA microrna screen to identify regulators of peritoneal fibrosis in a rat model of peritoneal dialysis.Transforming growth factor-β inhibits myocardial PPARγ expression in pressure overload-induced cardiac fibrosis and remodeling in micePressure overload-dependent membrane type 1-matrix metalloproteinase induction: relationship to LV remodeling and fibrosis.
P2860
Q24625500-88DB3610-5815-44EC-A2B3-468E606923FDQ26740102-F297D32D-D71F-4AD1-BC71-B09B436E60C7Q26745841-1BDCA06F-877B-47B6-AE24-4853290CD208Q27024714-82ECEF42-C3F0-4517-9A65-4C99B252296EQ27025551-7E99DA75-28A5-489D-A2AE-2A020C109F01Q27304522-5C90AD4D-9DDB-425F-9CEF-06165A859811Q28076570-54938C65-0A48-4E9D-8D39-980F4FEE19C9Q28248833-2B8E7C1F-9270-4B46-97E7-4E253DD04AADQ28507674-CDC78336-6F58-414B-9D50-2A8E0608C83DQ28507863-88E75025-C2C7-4DAE-95D0-6408D191DAB3Q28535743-2CE81F0D-1886-469F-BA58-A5E8044CC9C0Q28565620-35C34777-EDAA-4F8A-908C-E1471A233CC9Q30234828-E82CBF0A-85DB-4D87-839F-C2717E9645E1Q30384457-9EA0C0A3-9B71-4D27-A626-75569708B300Q30528600-9A753F08-9287-4B56-9D55-2AD4D2046F29Q33569405-A6C8F247-BC02-4C83-BA5B-1DFC10DA23A4Q33631086-1F662C3C-932A-4BE8-A6F9-E38C560D11BAQ33648136-A1B88E0B-81A7-4B76-B802-1576EC4A4E26Q33653498-0D6225EF-95E8-49F7-956E-0FAACD6EF332Q33721878-B462743B-4331-4A78-AC4C-D026B52F6B5DQ33753317-9A0D8845-A6BC-4264-9C47-08BCEA4C6A36Q33765909-7FF3DAAB-7935-4E8D-AC3F-7FE15E141A4DQ33792340-33D8A02A-98F1-4A1F-BAAD-8EB8BB29C744Q33822186-411D741C-5A6C-42EA-A21D-F1B9812B9DE8Q34088449-3B322B2E-B952-4584-A1E1-26C9BACD17FCQ34144673-E31C0ED8-635E-49A2-BBC9-EA86EF451005Q34269204-EC3205AE-B8FA-4256-925A-7C7EF6861AB5Q34273479-18A5C5B9-E6B7-429E-B70E-AA6225E27CFBQ34359362-B495A329-ED97-4506-B7D8-80E489A67593Q34550539-981ED5FD-D0CC-4DB2-A377-99E02ACD7124Q34602939-25B0F67E-CC7F-4319-BE55-4657B2574423Q35086438-33CA3F5D-5ADA-47BC-8263-48A50AE1196AQ35125156-BFE22D4F-F209-4F26-B769-9C84EF7DE551Q35161937-05C4BDC4-5527-47D8-AB71-9D388A1F1D7BQ35167896-5F06EF47-A7B3-498C-8A6C-2B5868AF0B19Q35527297-02AE9945-E3F8-43C0-8746-BE7331B767B4Q35576675-957F74B2-2935-4528-A35D-F20B6FD8F93BQ35605375-E15017CB-F041-4153-849A-4423E90DDFCAQ35885246-218F90B4-D2FF-4891-A682-0F7A17985246Q35900890-4B51D3BB-B0AB-48D0-9B06-87604B9EABC8
P2860
Molecular mechanisms that control interstitial fibrosis in the pressure-overloaded heart.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 28 September 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Molecular mechanisms that control interstitial fibrosis in the pressure-overloaded heart.
@en
Molecular mechanisms that control interstitial fibrosis in the pressure-overloaded heart.
@nl
type
label
Molecular mechanisms that control interstitial fibrosis in the pressure-overloaded heart.
@en
Molecular mechanisms that control interstitial fibrosis in the pressure-overloaded heart.
@nl
prefLabel
Molecular mechanisms that control interstitial fibrosis in the pressure-overloaded heart.
@en
Molecular mechanisms that control interstitial fibrosis in the pressure-overloaded heart.
@nl
P2860
P356
P1476
Molecular mechanisms that control interstitial fibrosis in the pressure-overloaded heart.
@en
P2093
Esther E Creemers
Yigal M Pinto
P2860
P304
P356
10.1093/CVR/CVQ308
P577
2010-09-28T00:00:00Z